Lesson 6: MGO Verification & Potency Confirmation

Clinical Context

Methylglyoxal concentration is the single most important chemical parameter defining medical-grade Manuka honey. MGO potency directly correlates with antibacterial efficacy in wound care applications. Honey sold at a specific UMF or MGO rating must contain the labeled concentration at time of purchase, not merely at time of initial testing. Sequential verification testing confirms that MGO levels have stabilized after maturation and will maintain the rated potency throughout the product's shelf life.

A single HPLC test provides a snapshot of MGO concentration at one moment. Sequential testing, with multiple measurements separated by defined time intervals, establishes the maturation trajectory. A rising MGO curve indicates ongoing DHA conversion with higher final potency ahead. A stable plateau confirms conversion is complete and the batch is ready for classification. A declining curve signals degradation that may require intervention or reclassification.

This SOP defines the testing methodology, laboratory requirements, grading correlation, and batch release criteria that transform raw analytical data into a certified potency guarantee.

HPLC Testing Methodology

High-Performance Liquid Chromatography Protocol

HPLC is the internationally accepted analytical method for quantifying MGO in honey. The technique separates methylglyoxal from the complex honey matrix based on molecular polarity, then measures its concentration against calibrated reference standards. HPLC provides accuracy to within plus or minus 5% when performed by accredited laboratories following validated methods.

• Sample Preparation: Honey dissolved in ultrapure water at standardized dilution ratio (typically 1:10 w/v), filtered through 0.45-micron syringe filter to remove particulates
• Column Type: Reversed-phase C18 column with guard column protection
• Detection: UV detection at 260 nm wavelength for MGO; 284 nm for DHA quantification
• Calibration: Five-point calibration curve using certified MGO reference standards spanning 50 to 2000 mg/kg
• Internal Standard: O-phenylenediamine (OPD) derivatization for enhanced detection sensitivity in low-MGO samples

Laboratory Accreditation Requirements

Testing laboratories must hold ISO 17025 accreditation with MGO analysis included in their scope of accreditation. Third-party proficiency testing through inter-laboratory comparison programs verifies ongoing analytical competency. Results from non-accredited laboratories are not accepted for batch release decisions, regardless of apparent accuracy.

Sequential Testing Protocol

Three-Stage Verification Sequence

Every batch undergoes a minimum of three HPLC tests before release authorization. Each test serves a distinct purpose in establishing potency confidence.

Stability Confirmation Rule

A batch qualifies for release when two consecutive HPLC tests, separated by a minimum of 90 days, produce MGO results within 10% of each other. This plateau confirmation indicates that DHA conversion has substantially completed and the rated MGO level will persist through shelf life. Batches where MGO continues rising by more than 10% between tests remain in maturation with extended monitoring until stabilization occurs.

MGO-to-UMF Grading Correlation

Classification Standards

The Unique Manuka Factor (UMF) grading system translates MGO concentration into a standardized potency rating recognized by regulatory bodies and clinical protocols worldwide. UMF certification requires testing by licensed laboratories and includes parameters beyond MGO alone.

UMF Certification Components

UMF grading evaluates four chemical markers in combination, not MGO alone. A batch must meet all four criteria simultaneously to receive UMF certification at a given tier:

1. Methylglyoxal (MGO): Minimum concentration corresponding to the target UMF tier as shown in the table above
2. Dihydroxyacetone (DHA): Residual DHA must be present, confirming natural Leptospermum origin rather than synthetic MGO addition
3. Hydroxymethylfurfural (HMF): Maximum 40 mg/kg for any UMF rating, with medical-grade operations targeting below 10 mg/kg
4. Leptosperin: Minimum 100 mg/kg, a chemical marker unique to Leptospermum nectar that authenticates botanical origin independently of pollen analysis

Batch Release Authorization

Release Decision Matrix

Batch release requires simultaneous satisfaction of all the following criteria. Failure on any single parameter prevents release at the intended classification tier.

• MGO Stability: Two consecutive tests within 10% confirming potency plateau
• HMF Compliance: Final HMF reading below 10 mg/kg for medical-grade, below 40 mg/kg for food-grade
• Diastase Integrity: Diastase number above 12, confirming enzymatic activity preservation
• Moisture Compliance: Final moisture reading below 17%
• Pollen Authentication: Leptospermum scoparium pollen dominance above 70%
• Contaminant Screening: 400+ pesticide multi-residue panel below detection limits
• Microbiological Testing: Total plate count, yeast, and mold within pharmaceutical specifications

Release Documentation

The Quality Assurance Manager signs the batch release certificate after verifying all criteria. This signed certificate authorizes the batch for packaging, labeling at the certified grade, and entry into the distribution chain. The release certificate references all contributing test reports by laboratory accession number and becomes the permanent quality record for that batch.

Post-Release Stability Monitoring

Shelf-Life Verification

Released batches enter a stability monitoring program that verifies potency maintenance throughout the stated shelf life (typically 3 to 5 years for properly stored medical-grade Manuka). Retained samples from each batch undergo annual HPLC retesting. If any retained sample drops below its rated MGO tier, the batch holder receives immediate notification, and remaining inventory may be reclassified or recalled depending on the magnitude of degradation.

Shelf-life studies also monitor HMF progression, diastase decline, and moisture stability over time. These longitudinal datasets refine predictive models for future batches and provide the evidence base supporting shelf-life claims on product labeling.

Critical Takeaways